These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 7254945)

  • 21. [Abnormal antithrombin III: abnormalities of heparin or protease binding domain].
    Sakuragawa N; Niiya K; Takahashi K; Hayashi T; Oguma Y; Saitoh S
    Rinsho Byori; 1993 May; 41(5):492-505. PubMed ID: 8350512
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Morphine pharmacokinetics in premature and mature newborn infants.
    Mikkelsen S; Feilberg VL; Christensen CB; Lundstrøm KE
    Acta Paediatr; 1994 Oct; 83(10):1025-8. PubMed ID: 7841696
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Antithrombin III substitution for optimization of the heparin effect during extracorporeal circulation in heart surgery].
    Dietrich W; Schroll A; Göb E; Barankay A; Richter JA
    Anaesthesist; 1984 Sep; 33(9):422-7. PubMed ID: 6496919
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The measurement of heparin and other therapeutic sulphated polysaccharides in plasma, serum and urine.
    Dawes J; Prowse CV; Pepper DS
    Thromb Haemost; 1985 Oct; 54(3):630-4. PubMed ID: 2935965
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Decreased concentrations of heparinoids are required to inhibit thrombin generation in plasma from newborns and children compared to plasma from adults due to reduced thrombin potential.
    Chan AK; Berry LR; Monagle PT; Andrew M
    Thromb Haemost; 2002 Apr; 87(4):606-13. PubMed ID: 12008942
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rate of protamine administration: its effect on heparin reversal and antithrombin recovery after coronary artery surgery.
    Zaidan JR; Johnson S; Brynes R; Monroe S; Guffin AV
    Anesth Analg; 1986 Apr; 65(4):377-80. PubMed ID: 3954111
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacokinetics of oral and intravenous indomethacin in preterm infants.
    Bhat R; Vidyasagar D; Fisher E; Hastreiter A; Ramirez JL; Burns L; Evans M
    Dev Pharmacol Ther; 1980; 1(2-3):101-10. PubMed ID: 6927543
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Post-dosage loading concentrations of theophylline and pharmacokinetic study after the fifth maintenance dosage in premature newborns with apnea].
    Rodríguez-Palomares C; Udaeta-Mora E; González-Treviño J; Juárez-Olguín H; Calderón-Mandujano B; Prado-Serrano A; Belmont-Gómez A
    Bol Med Hosp Infant Mex; 1991 Mar; 48(3):164-72. PubMed ID: 2064746
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacokinetics and efficacy of ropivacaine for continuous epidural infusion in neonates and infants.
    Bösenberg AT; Thomas J; Cronje L; Lopez T; Crean PM; Gustafsson U; Huledal G; Larsson LE
    Paediatr Anaesth; 2005 Sep; 15(9):739-49. PubMed ID: 16101704
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The effect of a thigh tourniquet on the pharmacokinetics of midazolam].
    Schmitt HJ; Batz GM; Götz H; Knoll RJ; Danner UG; Härtl LM
    Anaesthesist; 1991 Feb; 40(2):79-84. PubMed ID: 2048708
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The pharmacokinetics of D-penicillamine in neonates.
    Oroszlán G; Szabó T; Lakatos L; Márton G
    Acta Paediatr Hung; 1987; 28(2):143-6. PubMed ID: 3426856
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The biologic half-life of heparin.
    McAvoy TJ
    Clin Pharmacol Ther; 1979 Mar; 25(3):372-9. PubMed ID: 761447
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacokinetic modeling of heparin and its clinical implications.
    McAvoy TJ
    J Pharmacokinet Biopharm; 1979 Aug; 7(4):331-54. PubMed ID: 512841
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Volume of distribution and half-life of heparin after intravenous administration].
    Zöllner N; Kaiser W
    Res Exp Med (Berl); 1972; 158(2):89-94. PubMed ID: 4561302
    [No Abstract]   [Full Text] [Related]  

  • 35. Pharmacokinetics of cardiovascular drugs in children. Inotropes and vasopressors.
    Steinberg C; Notterman DA
    Clin Pharmacokinet; 1994 Nov; 27(5):345-67. PubMed ID: 7851053
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical pharmacokinetics of dipyrone and its metabolites.
    Levy M; Zylber-Katz E; Rosenkranz B
    Clin Pharmacokinet; 1995 Mar; 28(3):216-34. PubMed ID: 7758252
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Thrombosis Prevention and Anticoagulation Management in the Pediatric Patient with Congenital Heart Disease.
    Abdelghani E; Cua CL; Giver J; Rodriguez V
    Cardiol Ther; 2021 Dec; 10(2):325-348. PubMed ID: 34184214
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An evidence-based standardized protocol for anticoagulation following congenital heart surgery.
    Deshaies C; Poirier N; Khairy P
    Transl Pediatr; 2018 Oct; 7(4):369-371. PubMed ID: 30460190
    [No Abstract]   [Full Text] [Related]  

  • 39. Heparin-protamine balance after neonatal cardiopulmonary bypass surgery.
    Peterson JA; Maroney SA; Zwifelhofer W; Wood JP; Yan K; Bercovitz RS; Woods RK; Mast AE
    J Thromb Haemost; 2018 Oct; 16(10):1973-1983. PubMed ID: 30016577
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Duration of anticoagulant therapy in pediatric venous thromboembolism: Current approaches and updates from randomized controlled trials.
    Tarango C; Schulman S; Betensky M; Goldenberg NA
    Expert Rev Hematol; 2018 Jan; 11(1):37-44. PubMed ID: 29183221
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.